These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9521197)

  • 1. Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis.
    Couchoud C; Cucherat M; Haugh M; Pouteil-Noble C
    Transplantation; 1998 Mar; 65(5):641-7. PubMed ID: 9521197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation.
    Couchoud-Heyer C
    Cochrane Database Syst Rev; 2007 Jul; 1998(4):CD001320. PubMed ID: 17636667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation.
    Couchoud C
    Cochrane Database Syst Rev; 2000; (2):CD001320. PubMed ID: 10796773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
    Hodson EM; Ladhani M; Webster AC; Strippoli GF; Craig JC
    Cochrane Database Syst Rev; 2013 Feb; (2):CD003774. PubMed ID: 23450543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.
    Hodson EM; Jones CA; Webster AC; Strippoli GF; Barclay PG; Kable K; Vimalachandra D; Craig JC
    Lancet; 2005 Jun 18-24; 365(9477):2105-15. PubMed ID: 15964447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
    Hodson EM; Barclay PG; Craig JC; Jones C; Kable K; Strippoli GF; Vimalachandra D; Webster AC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003774. PubMed ID: 16235341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
    Hodson EM; Craig JC; Strippoli GF; Webster AC
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003774. PubMed ID: 18425894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
    Owers DS; Webster AC; Strippoli GF; Kable K; Hodson EM
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD005133. PubMed ID: 23450558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.
    Flechner SM; Avery RK; Fisher R; Mastroianni BA; Papajcik DA; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC
    Transplantation; 1998 Dec; 66(12):1682-8. PubMed ID: 9884259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
    Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S
    Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis.
    Boivin G; Erice A; Crane DD; Dunn DL; Balfour HH
    J Infect Dis; 1993 Aug; 168(2):332-5. PubMed ID: 8393055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database.
    Badley AD; Seaberg EC; Porayko MK; Wiesner RH; Keating MR; Wilhelm MP; Walker RC; Patel R; Marshall WF; DeBernardi M; Zetterman R; Steers JL; Paya CV
    Transplantation; 1997 Jul; 64(1):66-73. PubMed ID: 9233703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation.
    Dunn DL; Gillingham KJ; Kramer MA; Schmidt WJ; Erice A; Balfour HH; Gores PF; Gruessner RW; Matas AJ; Payne WD
    Transplantation; 1994 Mar; 57(6):876-84. PubMed ID: 8154035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
    Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
    Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
    Strippoli GF; Hodson EM; Jones CJ; Craig JC
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005133. PubMed ID: 16437521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients.
    Falagas ME; Vardakas KZ
    Clin Microbiol Infect; 2006 Jul; 12(7):603-5. PubMed ID: 16774555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
    Puius YA; Snydman DR
    Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis.
    Gagelmann N; Ljungman P; Styczynski J; Kröger N
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):2101-2109. PubMed ID: 29777868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.